No significant difference was noted between the groups for platelet recovery and levels of lactate dehydrogenase, creatinine, or haemoglobin (fig 5).
No significant differences were seen between the two groups for platelets or other coagulation parameters like antithrombin-III (Table 2).
In addition, there were no statistically significant differences between groups for engraftment, duration of thrombocytopenia, number of red blood cell and platelet transfusions, duration of antibiotic infusion days, and hospitalization time.
There were no differences between groups in time to platelet engraftment or in their requirement for platelet transfusions.
Similarly, the acute nadir counts were also analysed in the same way and revealed no significant difference between any of the treatment groups for haemoglobin (P=0.688), platelets (P=0.256), or total white cell count (P=0.505).
There was no significant difference between the groups for units of packed red blood cells, fresh-frozen plasmas and platelet concentrates that were transfused during the observation period on extracorporeal lung support (Table 3).
There were also no differences observed between the groups for any transfusion reaction (p = 0.07).No differences were seen in the incremental change in platelet count nor in transfusion reactions when comparing major ABO incompatible platelet transfusions with ABO compatible transfusions in a large study of critically ill children.
No statistically significant differences were noted between both groups in MPV, platelet count, or WBC count.
Although no significant between-group differences were found for both of these variables, this was the effect of a significantly larger use of platelet concentrates and purified AT in the H-group.
No significant differences were found between the three groups in platelet count (data not shown).
